Drug Trial Radar · NCT07217587
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
115
Planned (sponsor's estimate)
Start
Jan 5, 2026
Primary completion
Sep 28, 2027
Study completion Jan 29, 2029
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Oct 16, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess how well nipocalimab works when compared to efgartigimod in participants with generalized myasthenia gravis (a condition in which body's immune system mistakenly attacks and damages the connection between nerves and muscles causing muscle weakness).
Conditions
- Myasthenia Gravis
Interventions
NipocalimabDrug
Nipocalimab will be administered intravenously.
EfgartigimodDrug
Efgartigimod will be administered intravenously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Arms 1 and 2: Averaged Mean Percent Change from Baseline in Total Immunoglobulin G (IgG) Levels Over Weeks 8, 10 and 12Time frame: Baseline, Weeks 8, 10 and 12
Locations
31 sites in 5 countries. Site status is shown where the registry gives one.
Neurology Center of North Orange County
Fullerton, California · Recruiting
The Neurology Group
Pomona, California · Recruiting
Research of the Rockies LLC
Colorado Springs, Colorado · Recruiting
Advanced Neurology of Colorado
Fort Collins, Colorado · Completed
University of Connecticut
Farmington, Connecticut · Recruiting
SFM Clinical Research LLC
Boca Raton, Florida · Recruiting
HSHS St. Elizabeth's Hospital
O'Fallon, Illinois · Recruiting
Josephson Wallack Munshower Neurology, PC
Indianapolis, Indiana · Recruiting
Tulane Center for Clinical Research
New Orleans, Louisiana · Recruiting
Neurology Center Of New England PC
Foxborough, Massachusetts · Recruiting
Henry Ford Hospital
Detroit, Michigan · Recruiting
Michigan State University
East Lansing, Michigan · Recruiting
Equity Medical
New York, New York · Recruiting
Velocity Clinical Research, Inc.
Raleigh, North Carolina · Recruiting
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina · Recruiting
Neurology Clinic, PC
Cordova, Tennessee · Recruiting
Austin Neuromuscular Center
Austin, Texas · Recruiting
Texas Neurology
Dallas, Texas · Recruiting
The University of Texas Health Science Center at Houston
Houston, Texas · Recruiting
EvergreenHealth Neurology
Kirkland, Washington · Recruiting
Klinikum Altenburger Land GmbH
Altenburg, Germany · Recruiting
Katholisches Klinikum Bochum gGmbH
Bochum, Germany · Recruiting
Universitatsklinikum Freiburg
Freiburg im Breisgau, Germany · Recruiting
Rambam Medical Center
Haifa, Israel · Recruiting
Sourasky Medical Center
Tel Aviv, Israel · Recruiting
Hosp. Clinic de Barcelona
Barcelona, Spain · Recruiting
Hosp. Univ. Ramon Y Cajal
Madrid, Spain · Recruiting
Hosp. Univ. Infanta Sofia
Madrid, Spain · Recruiting
Hosp. Virgen Macarena
Seville, Spain · Recruiting
Hosp. Clinico Univ. de Valencia
Valencia, Spain · Recruiting
HOCH Health Ostschweiz Kantonsspital St.Gallen
Sankt Gallen, Switzerland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.